EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bacterial Contamination of Platelet Products

Michael R Jacobs, Bowen Zhou, Aditi Tayal, Robert W Maitta iD

Microorganisms · 26.01.2024 · 12 (2) · 258

DOI: 10.3390/microorganisms12020258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 26.01.2024. Verfasst von Michael R Jacobs und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transfusion of bacterially contaminated platelets, although rare, is still a major cause of mortality and morbidity despite the introduction of many methods to limit this over the past 20 years. The methods used include improved donor skin disinfection, diversion of the first part of donations, use of apheresis platelet units rather than whole-blood derived pools, primary and secondary testing by culture or rapid test, and use of pathogen reduction. Primary culture has been in use the US since 2004, using culture 24 h after collection of volumes of 4–8 mL from apheresis collections and whole-blood derived pools inoculated into aerobic culture bottles, with limited use of secondary testing by culture or rapid test to extend shelf-life from 5 to 7 days. Primary culture was introduced in the UK in 2011 using a “large-volume, delayed sampling” (LVDS) protocol requiring culture 36–48 h after collection of volumes of 16 mL from split apheresis units and whole-blood derived pools, inoculated into aerobic and anaerobic culture bottles (8 mL each), with a shelf-life of 7 days. Pathogen reduction using amotosalen has been in use in Europe since 2002, and was approved for use in the US in 2014. In the US, recent FDA guidance, effective October 2021, recommended several strategies to limit bacterial contamination of platelet products, including pathogen reduction, variants of the UK LVDS method and several two-step strategies, with shelf-life ranging from 3 to 7 days. The issues associated with bacterial contamination and these strategies are discussed in this review.

Schlagwörter

Stichwörter der Autor:innen

bacterial contaminationplatelet safetyrisk control strategies

Autor:innen und Institutionen

  • Department of Pathology, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.

ORCID-Profile: Robert W Maitta

Zitieren

APA

Jacobs, M. R., Zhou, B., Tayal, A., & Maitta, R. W. (2024). Bacterial Contamination of Platelet Products. Microorganisms, 12(2), 258. https://doi.org/10.3390/microorganisms12020258

Vancouver

Jacobs MR, Zhou B, Tayal A, Maitta RW. Bacterial Contamination of Platelet Products. Microorganisms. 2024;12(2):258. doi:10.3390/microorganisms12020258

BibTeX
@article{Jacobs2024,
  author = {Jacobs, Michael R and Zhou, Bowen and Tayal, Aditi and Maitta, Robert W},
  title = {Bacterial Contamination of Platelet Products},
  journal = {Microorganisms},
  year = {2024},
  volume = {12},
  number = {2},
  pages = {258},
  doi = {10.3390/microorganisms12020258}
}
Kostenlos starten →